Literature DB >> 27154966

RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Luis G Carvajal-Carmona1, Ian Tomlinson2, Ruta Sahasrabudhe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27154966      PMCID： PMC5017950          DOI： 10.1093/jnci/djw108

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Jerneja Tomsic; Huiling He; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

2.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Marialuisa Sponziello; Cosimo Durante; Sebastiano Filetti
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

3.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Ximeng Zhao; Xiaoyi Li; Xue Zhang
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

4.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

5.  HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Authors:  Tao Zhang; Mingzhao Xing
Journal:  J Natl Cancer Inst       Date:  2016-02-01       Impact factor: 13.506

6.  The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.

Authors:  Ruta Sahasrabudhe; Jacob Stultz; John Williamson; Paul Lott; Ana Estrada; Mabel Bohorquez; Claire Palles; Guadalupe Polanco-Echeverry; Emma Jaeger; Lynn Martin; Maria Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal-Carmona
Journal:  J Clin Endocrinol Metab       Date:  2015-12-21       Impact factor: 5.958

7.  HABP2 G534E Variant in Papillary Thyroid Carcinoma.

Authors:  Jerneja Tomsic; Rebecca Fultz; Sandya Liyanarachchi; Huiling He; Leigha Senter; Albert de la Chapelle
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240
  7 in total
  4 in total

1.  HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Authors:  Maisa Pinheiro; Sandra Aparecida Drigo; Renata Tonhosolo; Sonia C S Andrade; Fabio Albuquerque Marchi; Igor Jurisica; Luiz Paulo Kowalski; Maria Isabel Achatz; Silvia Regina Rogatto
Journal:  Oncotarget       Date:  2017-06-20

2.  Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.

Authors:  Paola Caria; Silvia Cantara; Daniela Virginia Frau; Furio Pacini; Roberta Vanni; Tinuccia Dettori
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

Review 3.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

4.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.